See also this year's filing and all EDGAR filings for this company.
PDF Report 0001261734_2012_Aeolus_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001261734, Aeolus Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,258,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 32,000 |
| 4 | LiabilitiesCurrent | 2,144,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 23,405,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,668,000 |
| 9 | ResearchAndDevelopmentExpense | 5,055,000 |
| 10 | remainder_Expenses | -21,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 9,043,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,290,000 |
| 1 | Liabilities | 25,549,000 |
| 2 | Expenses | 8,702,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -23,259,000 |
| 5 | NetIncome | 341,000 |
| 6 | ComprehensiveNetIncome | 341,000 |
| 7 | BaseVar | 22,792,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.62 |
| 9 | EconomicCapitalRatio | 0.495 |
Edgar->Model Mapping
Feature Distribution
